Literature DB >> 1684756

Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies.

M Haltia1, J Kovanen, L G Goldfarb, P Brown, D C Gajdusek.   

Abstract

In 1974-1984 30 patients died with a diagnosis of Creutzfeldt-Jakob disease (CJD) in Finland (annual mortality rate of CJD 0.9 per million population for the years 1979-1984). Six of these patients (20%) were familial, all belonging to the same kindred. The pedigree now includes 15 affected members in four generations, and the occurrence of disease is consistent with an autosomal dominant mode of inheritance. The clinical features of CJD in this family are in most respects typical of the familial disease described elsewhere. However, the mean age at onset is 47, periodic EEG activity has not been observed, and the mean duration of illness of 27.5 months is longer than usual for either familial or sporadic CJD. Neuropathological examination of brain biopsy and autopsy specimens revealed spongiform change without amyloid plaques, and brain tissue from one patient transmitted disease to a capuchin monkey. In an analysis of the histocompatibility antigens of the family, CJD was not linked with a single haplotype, but at least 12 out of 13 CJD patients shared the HLA antigen A28. Molecular genetic studies disclosed a new G-to-A mutation in codon 178 of the PRNP gene (resulting in a substitution of asparagine for aspartic acid) in the DNA of eight family members with CJD but not in any of ten currently healthy first degree relatives of the patients, or 86 controls. The codon 178 mutation thus seems to co-segregate with CJD in this family. Linkage analysis gave a LOD score value of 3.6.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684756     DOI: 10.1007/bf00143128

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred.

Authors:  L G Goldfarb; M Haltia; P Brown; A Nieto; J Kovanen; W R McCombie; S Trapp; D C Gajdusek
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

2.  Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia.

Authors:  L G Goldfarb; E Mitrová; P Brown; B K Toh; D C Gajdusek
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

3.  Identical mutation in unrelated patients with Creutzfeldt-Jakob disease.

Authors:  L G Goldfarb; P Brown; D Goldgaber; R M Garruto; R Yanagihara; D M Asher; D C Gajdusek
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

4.  Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome.

Authors:  D Goldgaber; L G Goldfarb; P Brown; D M Asher; W T Brown; S Lin; J W Teener; S M Feinstone; R Rubenstein; R J Kascsak
Journal:  Exp Neurol       Date:  1989-11       Impact factor: 5.330

5.  Familial Creutzfeldt-Jakob disease.

Authors:  M Haltia; J Kovanen; H Van Crevel; G T Bots; S Stefanko
Journal:  J Neurol Sci       Date:  1979-08       Impact factor: 3.181

6.  Creutzfeldt-Jakob disease. II. Clinical, pathologic, and genetic study of a family.

Authors:  W W May; H H Itabashi; R N De Jong
Journal:  Arch Neurol       Date:  1968-08

7.  Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis.

Authors:  P Brown; P Rodgers-Johnson; F Cathala; C J Gibbs; D C Gajdusek
Journal:  Ann Neurol       Date:  1984-09       Impact factor: 10.422

8.  Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.

Authors:  K Hsiao; Z Meiner; E Kahana; C Cass; I Kahana; D Avrahami; G Scarlato; O Abramsky; S B Prusiner; R Gabizon
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

9.  Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome.

Authors:  J Tateishi; T Kitamoto; K Doh-ura; Y Sakaki; G Steinmetz; C Tranchant; J M Warter; N Heldt
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

10.  Cerebral MR and CT imaging in Creutzfeldt-Jakob disease.

Authors:  J Kovanen; T Erkinjuntti; M Iivanainen; L Ketonen; M Haltia; R Sulkava; J T Sipponen
Journal:  J Comput Assist Tomogr       Date:  1985 Jan-Feb       Impact factor: 1.826

View more
  5 in total

1.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

2.  Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72-year-old celloidin-embedded brain tissue.

Authors:  H A Kretzschmar; M Neumann; D Stavrou
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 3.  Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses.

Authors:  D C Gajdusek
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

Review 4.  Small-molecule theranostic probes: a promising future in neurodegenerative diseases.

Authors:  Suzana Aulić; Maria Laura Bolognesi; Giuseppe Legname
Journal:  Int J Cell Biol       Date:  2013-11-12

Review 5.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.